MEET THE VITACCESS TEAM AT ISPOR EUROPE 2018 IN BARCELONA BOOTH #326

The Vitaccess team will be attending ISPOR Europe in Barcelona 10-14 November at booth #326 and presenting a poster about hereditary motor and sensory neuropathy with Pharnext. Come and say hello, we’ve got lots to talk to you about!

From cancer to rare diseases, Vitaccess is giving patients a voice. Our evidence generation digital platform MyRealWorld™ hosts bespoke study apps that are designed to be patients’ companions in the management of their diseases. They can record their treatments and symptoms in the real world in real time. With a clinically validated knowledge feature, they can access real information about their diagnosis. The platform can also offer a Community app module, enabling participants to make contact and offer support to each other. Our apps also allow patients to scan and store electronic documents to share with their clinical team.

3 apps.png

We launched the Melanoma UK digital registry app a year ago and today, we are collecting real world evidence from more than 370 registered and active users. Aggregated and anonymised data is available for free to academic researchers and to industry through a subscription service.

Since ISPOR in Baltimore last May, we have launched two new apps in rare diseases and have attended the AANEM and NORD Summit in Washington DC.

myThalLog is an app sponsored by clinical stage company bluebird bio that is running an e-diary project in 5 countries to measure the time burden of transfusion-dependent beta thalassemia on patients’ daily lives.

CMT&Me is a bespoke app designed for patients living with Charcot-Marie-Tooth disease in France, Germany, Italy, Spain, the UK and US. The international observational study is sponsored by Pharnext, a biopharmaceutical company that has just announced positive topline results from its pivotal Phase 3 clinical trial (PLEO-CMT) evaluating two doses of PXT3003 compared to placebo during 15 months for the treatment of Charcot-Marie-Tooth type 1A disease (CMT1A).

 Hara Kousoulakou presenting our poster at ISPOR Baltimore about “Real-world EQ-5D-5L utility values in patients with melanoma derived using a digital “bring your own device” platform

Hara Kousoulakou presenting our poster at ISPOR Baltimore about “Real-world EQ-5D-5L utility values in patients with melanoma derived using a digital “bring your own device” platform

Vitaccess and Pharnext will present a poster at ISPOR Barcelona entitled “Development of a Digital App and Innovative Recruitment for an International Real-World Observational Study in Charcot-Marie-Tooth Disease”.

Don’t miss our presentation at the Research Poster Presentations, Session, PND: Neurological Disorders. Our presentation code is PND148 and our poster position is P7. We look forward to seeing you on Monday 12th November between 15:45 and 19:15.   

If you’d like to book a meeting, a demo or both, please get in touch!

We’re very excited to share what we’ve been up to and hope we can help you too with your real-world evidence and HEOR needs.